U.S. CLINICAL NUTRITION MARKET ANALYSIS

U.S. Clinical Nutrition Market, By Type (Enteral Nutrition (Standard Nutrition and Disease Specific Nutrition) and Parenteral Nutrition (Amino Acids, Carbohydrates, Vitamins and Minerals and Others (Fibers, etc.)), By Form (Powder, Liquid and Others (Solid,etc.)), By Age Group (Infant Nutrition, Adult Nutrition and Geriatric Nutrition), By Application (Diabetes, Gastrointestinal Diseases, Cancer, Neurological Disorder, Metabolic Syndrome and Other (Critical Care, etc.)), By End User (Hospitals, Home Care Setting, Long Term Care Facilities, Ambulatory Surgical Centers and Others (Research Institutes, etc.))

Published In : Sep 2023
Code : CMI4412
Pages :154
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Side effects of nutritional products: The major factors restraining growth of the U.S. clinical nutrition market is side effects and complications caused by products indicated for clinical nutrition, if consumed in excess. Excess consumption of any nutritional product can lead to life threating conditions. For example, parenteral nutritional therapy can lead to serious and life threating conditions such as refeeding syndrome or liver dysfunction. For instance, in December 2021, according to a study published by National Center for Biotechnology Information, refeeding syndrome describes the adverse medicinal and biochemical problems that may result from feeding malnourished patients through any route, be it oral, enteral or parenteral, whereas in 2020, 60% of the patients given parenteral nutrition were at risk of refeeding problems.

Counterbalance: To overcome these challenges, patient must consult their physician before taking any kind of clinical nutrition to avoid later consequences.

U.S. Clinical Nutrition Market- Cross Sectional Analysis:

Rising number of new product launches related to powder form is expected to propel market growth in the U.S., over the forecast period. For instance, in January 2022, Danone S.A., a global food company, announced the launch of a powder version of medical nutrition drink named Souvenaid. Souvenaid is a food for special medical purposes in the dietary management of early Alzheimer's disease.

U.S. Clinical Nutrition Market Report Snapshots